Know Labs, Inc. (KNW)
NYSEAMERICAN: KNW · IEX Real-Time Price · USD
0.404
-0.006 (-1.46%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Company Description
Know Labs, Inc., together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States.
The company’s proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes.
The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018.
Know Labs, Inc. was incorporated in 1998 and is based in Seattle, Washington.
Know Labs, Inc.
| Country | United States |
| Founded | 1998 |
| Industry | Scientific & Technical Instruments |
| Sector | Technology |
| Employees | 11 |
| CEO | Ronald P. Erickson J.D. |
Contact Details
Address: 619 Western Avenue, Suite 610 Seattle, Washington 98104 United States | |
| Phone | 206-903-1351 |
| Website | knowlabs.co |
Stock Details
| Ticker Symbol | KNW |
| Exchange | NYSEAMERICAN |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001074828 |
| ISIN Number | US4992381032 |
| Employer ID | 90-0273142 |
| SIC Code | 3829 |
Key Executives
| Name | Position |
|---|---|
| Ronald P. Erickson J.D. | Founder, Chief Executive Officer, Treasurer and Chairman |
| Peter Joseph Conley | Chief Financial Officer and Senior Vice President of Intellectual Property |
| Jessica English | Chief Marketing Officer |
| Dr. James H. Anderson Jr., M.D. | Chief Medical Officer and Chairman of Medical, Scientific and Regulatory Advisory Board |
| Steven T. Kent | Chief Product Officer |
| Leonardo Trautwein | Chief Commercial Officer |
| Jordyn Hujar | Chief of Staff |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 11, 2024 | 8-K | Current Report |
| Jul 9, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jul 2, 2024 | FWP | Free Writing Prospectus |
| Jul 2, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jun 17, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Jun 3, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| May 15, 2024 | 10-Q | Quarterly Report |
| Apr 16, 2024 | EFFECT | Notice of Effectiveness |
| Apr 12, 2024 | 424B3 | Prospectus |
| Apr 9, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |